Subscribe
Digital Therapeutics Edition with Eugene Borukhovich

Digital Therapeutics Edition with Eugene Borukhovich

A Limited Series produced by Digital Health Today

Latest From Series

Ep16: The Mind(s) Behind Germany’s Digital Health Care Act

During his conscripted service with the German Navy, Christian Dierks learned that if you’re the person in charge of rules and administration, you can bring about a lot of change. He took this lesson with him to law school and in the creation of his own law and healthcare consultancy firm, Dierks+Company. Christian was instrumental in the creation of Germany’s 2019 Digital Health Care Act (known as DVG in Germany), which mandates full reimbursement of any prescribed digital health application. In fact, Christian was involved in setting up the legal framework for digital health applications (DiGA) in Germany—and importantly, he convinced health insurers in Germany not to nickname them DiVA, an acronym which would have carried distinctly less gravitas. Starting with this episode, Eugene says farewell (for now) to DTx trailblazers in the United States, and shifts the focus to leaders in Europe, where Christian and other thought leaders are working to broaden access to digital health solutions. Eugene and Christian recorded this episode in January, and since then, there have been some exciting updates to the status of DVG. Namely, the list of approved digital therapies for reimbursement has grown to 13, and Germany is starting to publish early data on the impact of the measure. >>Click here to read the transcript Guest Links and Resources: Connect with Christian Dierks: LinkedIn | Twitter Visit Dierks+Company: LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
April 13, 2021

Ep15: Treating Depression, Anxiety, and Sleep Disorders with Happify

Chris Wasden came to the digital therapeutics space via a circuitous route through Wall Street, Main Street, and academia. A pro at finding ways to leverage digital solutions in the pharmaceutical industry, he was asked to lead HappifyDTx’s digital therapeutics business after he and his students identified it as the best digital health company in the world. Happify just closed an impressive $73 million funding round and continues to innovate clinically validated tools to treat depression, anxiety, and sleep disorders. In this episode, Chris tells Eugene how Happify’s founders moved from creating video games to digital health tools, and why the team took on the mammoth effort of creating an FDA-quality management system for its platform of products. As a result of their hard work, Chris says Happify is the only DTx company out there that has a legitimate, placebo-controlled RCT. >>Click here to read the transcript Guest Links and Resources: Connect with Chris Wasden: LinkedIn | Twitter Visit Happify Health: Twitter| LinkedIn | Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
April 6, 2021

Ep14: Building the Genentech of Digital Therapeutics

Corey McCann says he always wanted to name a company after a fruit, and when he and his team saw an opportunity to “pair” drugs and software to treat serious disease and improve patient outcomes, the name Pear Therapeutics was born. Of course, the other inspiration for the creation of Pear Therapeutics was Genentech, in that Corey and his team wanted to build something big and capitalize on the hundreds of opportunities they see to modify standards of efficacy with software solutions. Corey, Eugene, and Brian talk about Pear’s early foray into the digital therapeutics space and how Pear’s digital therapies incorporate doctors, nurses, health coaches, and other human counselors. Also, for any entrepreneurs looking to start their own venture, Corey has several pearls of wisdom for you—one of which is to choose your investors and board members very wisely. Finally, Corey offers his predictions about the future of prescription digital therapeutics and the policy solutions needed to make PDTs viable for all patients. >>Click here to read the transcript Guest Links and Resources: Connect with Corey McCann: LinkedIn | Twitter Visit Pear Therapeutics: Twitter| LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
March 30, 2021

Ep13: The New Breed of DTx May Not Be a DTx At All

Ask Chris Bergstrom what gets him out of bed in the morning, and he says very simply: “scale, scale, scale.” Chris brings a powerful blend of experience in start-ups, large companies, and the life sciences to his role as president of Amalgam Rx, a digital platform that brings providers and life sciences companies together to grow digital health solutions. Chris and Eugene talk about Amalgam’s origins and capabilities, and in response to a question from Brian Dolan about Amalgam’s recent acquisition of Avhana Health, Chris reveals that Amalgam has been lucky enough to start off as a fully self-funded venture. Finally, listen in as Chris and Eugene discuss whether the term “digital therapeutic” has become passé. >>Click here to read the transcript Guest Links and Resources: Connect with Chris Bergstrom: LinkedIn Visit Amalgam Rx: LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
March 23, 2021

Ep12: Improving Symptoms of Autoimmune Disorders with DTx Solutions

As an engineer, Melinda Decker could have designed widgets or Styrofoam cups or even gone into winemaking. But her passion for improving patient outcomes led her to digital therapeutics, and eventually to Mymee, a direct-to-consumer platform that helps people with autoimmune disorders manage their symptoms. Mymee recognizes that behavior change is hard, so they combine a user-friendly app and data analytics with health coaching, to help users identify their triggers and make long-lasting lifestyle changes that lessen the severity of their symptoms and improve their overall health. Since its founding in 2017, Mymee has collaborated on two publications and recently closed a funding round of $8.7 million. Join Eugene and Melinda’s conversation about digital therapeutics vs. disease management and the path the Mymee team took to getting their solution off the ground. >>Click here to read the transcript Guest Links and Resources: Connect with Melinda Decker: LinkedIn Visit Mymee: Twitter | LinkedIn | Facebook | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
March 16, 2021

Ep11: How to Digitize Cognitive Behavioral Therapy and Other Non-Drug Interventions

When Peter Hames struggled with insomnia, he couldn’t get access to any treatment other than sleeping pills. Out of “desperation,” he said, Peter self-administered a cognitive behavioral therapy (CBT) course and within weeks was sleeping like a baby. This experience—and his background in experimental psychology and technology—led him to co-found Big Health, a digital therapeutics (DTx) company whose mission is to “help millions back to good mental health.” With 53 peer-reviewed papers and 13 randomized control trials, Big Health is also one of the only DTx companies in the world with an evidence base of its size, rigor, and quality. Join Eugene and Peter as they talk about the early days of digital therapeutics, Big Health’s unique direct-to-consumer approach in the UK and the US, and its deep-rooted commitment to clinical evidence and supporting science. >>Click here to read the transcript Guest Links and Resources: Connect with Peter Hames: LinkedIn Visit Big Health: Twitter | LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
March 9, 2021

Listen on your favorite player

New to Podcasts? It's easy to get started!

About Digital Health Today - Digital Therapeutics Edition

Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.
View All Episodes

Host

Eugene Borukhovich

Eugene Borukhovich

Eugene is a serial intra and entrepreneur, executive, venture builder, speaker & board advisor with a focus in digital health. Eugene is a Chairman and Founding Board Member at YourCoach Health and founder of Initium Impact Ventures. Prior to YourCoach, Eugene served as a Global Head of Digital Health at Bayer. He has also co-founded and sold a doctor rating startup and a consulting company. Eugene enjoys running, writing, traveling and spending time with his family.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.